Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
NCT ID: NCT06773650
Last Updated: 2025-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
385 participants
OBSERVATIONAL
2025-01-08
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible).
The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Probiotics on Lactose Intolerance
NCT01593800
Effect of a Probiotic With High Beta-galactosidase Activity on Patients With Lactose Intolerance
NCT05367453
Effect of B.Bifidum 900791 Intake in Adult With Hypolactasia and Lactose Intolerance
NCT03952988
Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution
NCT03814668
Effect of I31 Probiotic on Lactose Intolerance
NCT04164394
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients completing online survey
The online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding Lactose Intolerance
Completion of online survey
The online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding LI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Completion of online survey
The online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding LI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to complete the online survey
Exclusion Criteria
* Subjects not available to answer the online survey
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Institute of Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European Institute of Oncology
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UID 4675
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.